DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 3,675.00
+55.00 (1.52%)
At close: Oct 2, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 90.41 billion as of October 2, 2026. Its market cap has decreased by -2.60% in one year.
Market Cap
90.41B
Enterprise Value
79.77B
Revenue
73.28B
Ranking
n/a
PE Ratio
274.93
Stock Price
3,675.00
ChartMarket Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 90.41B, a decrease of -45.30%. That is a compound annual growth rate of -9.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 90.41B | -40.46% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ingenia Therapeutics | 1.43T |
| Penetrium Bioscience | 412.92B |
| HLB bioStep | 49.46B |
| P&K Skin Research Center | 47.65B |
| Kolmar BioTech | 39.04B |
| SLS BIO | 26.89B |
| C&R Research | 26.38B |
| DT&CRO CO. | 25.22B |